Details for New Drug Application (NDA): 062717
✉ Email this page to a colleague
NDA 062717 describes UNIPEN, which is a drug marketed by Wyeth Ayerst and is included in five NDAs. Additional details are available on the UNIPEN profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for 062717
| Tradename: | UNIPEN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | nafcillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062717
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 16, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 16, 1986 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 16, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
